The test, developed in part by Johns Hopkins researchers, will dramatically increase access to early detection and treatment ...

The current quarter introduced the 15% onetime stock dividend and confirmed accelerated site activation for OVATION 3, compared to the previous quarter's focus on initial site readiness and ...

Imunon, Inc. ( NASDAQ: IMNN) Q2 2025 Earnings Conference Call August 5, 2025 11:00 AM ET Douglas V. Faller - Chief Medical Officer Khursheed Anwer - Executive VP & Chief Scientific Officer Kimberly ...

Stock dividend issued to IMUNON shareholders reflects confidence in clinical programs, long-term growth strategy and dedication to rewarding sharehol ...

Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

"Alzheimer's disease impacts too many people, more than breast cancer ... Research Center, also funded by the NIH. There has ...

Rectal cancer chemoradiotherapy was tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

This manuscript presents an in-depth analysis of gene expression across multiple brown algal species with differing life histories, providing convincing evidence for the conservation of life ...

Epilepsy is a serious and common neurological condition, characterised by recurring, unprovoked seizures, affecting ...

Historically, sex-related differences have been underexplored in neurology. It is important to highlight the distinction ...